Q3 2025 Holdings
Filed 2025-11-14 | 90 holdings | $499.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $63.5M | 4,197,187 | 12.7% |
| Uniqure NV(QURE) | SHS | N90064101 | $30.5M | 522,155 | 6.1% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $27.0M | 726,204 | 5.4% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $25.6M | 1,589,580 | 5.1% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $25.2M | 1,734,659 | 5.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $21.0M | 1,366,205 | 4.2% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $15.9M | 655,385 | 3.2% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $15.4M | 2,110,152 | 3.1% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $15.3M | 1,017,311 | 3.1% |
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $14.6M | 152,325 | 2.9% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $14.1M | 166,273 | 2.8% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $10.1M | 371,825 | 2.0% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $9.2M | 91,444 | 1.9% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $9.2M | 12,465 | 1.8% |
| Surrozen Inc(SRZN) | COM NEW | 86889P208 | $9.2M | 713,463 | 1.8% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $8.7M | 185,380 | 1.7% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $8.6M | 917,630 | 1.7% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $7.8M | 545,275 | 1.6% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $7.8M | 411,893 | 1.6% |
| Vistagen Therapeutics Inc(VTGN) | COM | 92840H400 | $7.7M | 2,488,685 | 1.6% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $7.7M | 192,295 | 1.5% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $7.2M | 241,637 | 1.5% |
| Celcuity Inc(CELC) | COM | 15102K100 | $6.8M | 136,710 | 1.4% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $6.6M | 127,435 | 1.3% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $6.3M | 43,419 | 1.3% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $6.0M | 474,612 | 1.2% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $6.0M | 158,112 | 1.2% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $5.8M | 121,410 | 1.2% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $5.1M | 39,072 | 1.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $5.0M | 114,053 | 1.0% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $4.3M | 150,573 | 0.9% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $4.2M | 359,470 | 0.8% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $3.8M | 8,207 | 0.8% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $3.8M | 276,884 | 0.8% |
| Incyte Corp(INCY) | COM | 45337C102 | $3.7M | 43,754 | 0.7% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $3.6M | 129,335 | 0.7% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $3.2M | 350,710 | 0.6% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $3.2M | 47,954 | 0.6% |
| Nektar Therapeutics(NKTR) | COM NEW | 640268306 | $3.0M | 53,201 | 0.6% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $3.0M | 15,149 | 0.6% |
| Tectonic Therapeutic Inc(TECX) | COM | 878972108 | $3.0M | 188,999 | 0.6% |
| Harrow Inc(HROW) | COM | 415858109 | $2.8M | 57,619 | 0.6% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $2.7M | 839,669 | 0.6% |
| Equillium Inc(EQ) | COM | 29446K106 | $2.7M | 1,908,935 | 0.5% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $2.6M | 6,264 | 0.5% |
| CG Oncology Inc(CGON) | COM | 156944100 | $2.5M | 63,019 | 0.5% |
| Invesco QQQ TR(QQQ) | UNIT SER 1 | 46090E103 | $2.3M | 3,797 | 0.5% |
| Bridgebio Oncology Therapeut(BBOT) | COM NEW | 107924102 | $2.2M | 186,614 | 0.4% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $2.1M | 245,378 | 0.4% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $2.0M | 166,461 | 0.4% |